CEO-TWO
- Product NDC
- 0283-1023
- 11-digit product format
- 002831023
- Labeler code
- 0283
- Product ID
- 0283-1023_42e0774e-b617-290d-e063-6394a90a199e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Laxative
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Beutlich Pharmaceuticals, LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-10-15
- Substance
- POTASSIUM BITARTRATE; SODIUM BICARBONATE
- Active strength
- .9; .6 g/5.7g; g/5.7g
- Pharmacologic classes
- Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEO-TWO
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM BITARTRATE | .9 g/5.7g |
| SODIUM BICARBONATE | .6 g/5.7g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NPT6P8P3UU | Internal UNII lookup |
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08670636-5795-4db0-e063-6294a90afa4b | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0283-1023-00 | CEO-TWO | 5.7 g in 1 DOSE PACK | SUPPOSITORY | 5.7 | 3 | |
| 0283-1023-02 | CEO-TWO | 2 in 1 BOX | SUPPOSITORY | 2 | 3 | |
| 0283-1023-36 | CEO-TWO | 6 in 1 BOX | SUPPOSITORY | 6 | 3 | |
| 0283-1023-54 | CEO-TWO | 54 in 1 BOX | SUPPOSITORY | 54 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0283-1023-02 | EA - Each | 0283-1023 | d7803fbb-22f6-4acb-bdd2-b3da0cb16667 | 1 | 2025-08-11 |
| 0283-1023-36 | EA - Each | 0283-1023 | 299afce1-70d3-4bcd-88c0-094182298613 | 1 | 2025-08-11 |
| 0283-1023-54 | EA - Each | 0283-1023 | aab567b9-183d-4296-a18e-a6c0a9c6cd3e | 1 | 2025-08-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2026-11-06 | Warnings | M007 |
| Sennosides | SENNOSIDES | REMEDYREPACK INC. | 3873abcd-8312-47d1-bccf-4265e1e32861 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | CALCIUM POLYCARBOPHIL | Target Corporation. | e5473950-06f4-4ea4-975b-3ac94957e776 | 2026-11-06 | Warnings | M007 |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2026-11-05 | Warnings | M007 |
| up and up gentle laxative | BISACODYL | Target Corporation | 4a29dc2b-b68f-471b-a84e-4a5096aa3748 | 2026-11-05 | Warnings | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2026-11-04 | Warnings | M007 |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | SAFEWAY | 08e2e8b0-90b3-48d6-a72a-40688c74771a | 2026-11-03 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-11-02 | Warnings, Adverse reactions | M007 |
| Gentle Laxative Stimulant Laxative | BISACODYL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | bcd3c07d-bd83-4452-9736-35c85db30c15 | 2026-10-29 | Warnings | M007 |
| Quality Choice | CALCIUM POLYCARBOPHIL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f1e69c65-c1b0-459f-9a12-b1a92b90036b | 2026-10-29 | Warnings | M007 |
| CDMA Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 62bbcaf2-1d0c-485f-9159-685700aa3418 | 2026-10-29 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-10-29 | Warnings, Adverse reactions | M007 |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2026-10-27 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 636188 | CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository [Ceo-Two] | SBD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository | SCD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0283-1023-00 | 00283102300 | 5.7 g in 1 DOSE PACK | 5.7 g | Historical | |||
| 0283-1023-02 | 00283102302 | 2 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 2 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-36 | 00283102336 | 6 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 6 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-54 | 00283102354 | 54 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 54 dose pack | 2023-10-15 | No | No | Current |